Wealth Enhancement Advisory Services
NUVB icon

Wealth Enhancement Advisory Services’s Nuvation Bio NUVB Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Buy
81,811
+7,331
+10% +$35.8K ﹤0.01% 2735
2026
Q1 		$328K Buy
74,480
+12,085
+19% +$67.3K ﹤0.01% 2682
2025
Q4 		$530K Sell
62,395
-1,163
-2% -$7.2K ﹤0.01% 2429
2025
Q3 		$233K Buy
63,558
+32,639
+106% +$88.9K ﹤0.01% 2994
2025
Q2 		$64.6K Buy
+30,919
New +$64.4K ﹤0.01% 3198
2025
Q1 		– Sell
-10,140
Closed -$27K – 3100
2024
Q4 		$27K Buy
+10,140
New +$26.1K ﹤0.01% 2894

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Wealth Enhancement Advisory Services's NUVB Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Nuvation Bio (NUVB) stake by 9.8% in Q2 2026, buying an estimated $35.8K and bringing the position to 81,811 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #2735.

Wealth Enhancement Advisory Services first reported a position in NUVB in Q4 2024 and has held it in 6 quarters since. The position peaked at $530K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Wealth Enhancement Advisory Services held 81,811 shares of Nuvation Bio worth $475K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 7,331 Nuvation Bio shares in Q2 2026, an estimated $35.8K.
  • Nuvation Bio made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2735 holding.
  • Wealth Enhancement Advisory Services first reported a position in Nuvation Bio in Q4 2024 and has held it in 6 quarters since.
  • Wealth Enhancement Advisory Services's Nuvation Bio position peaked at $530K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.